Late life increase in body mass index slows cognitive and functional decline in AD.
Cerebrovascular risk factors have a combined effect over cognitive improvement in AD.
Neuroleptics may enhance functionality by improving behavioural symptoms.
Side effects of anti-psychotics lead to steeper cognitive decline.
APOE4 + carriers have decreased participation in physical activities.